PTC Therapeutics Inc
NASDAQ:PTCT
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
PTC Therapeutics Inc
NASDAQ:PTCT
|
US |
|
B
|
Banco Bilbao Vizcaya Argentaria SA
SWB:BOY
|
ES |
|
C
|
Citizens Financial Group Inc
F:1C5
|
US |
|
C
|
CME Group Inc
SWB:MX4A
|
US |
|
N
|
Nextera Energy Inc
DUS:FP3
|
US |
|
I
|
Investec PLC
DUS:IVKA
|
UK |
|
N
|
National Grid PLC
F:NNGD
|
UK |
|
S
|
Standard Chartered PLC
F:STD
|
UK |
|
T
|
Trane Technologies PLC
F:2IS
|
IE |
|
HD Hyundai Heavy Industries Co Ltd
KRX:329180
|
KR |
|
Fuji Electric Co Ltd
TSE:6504
|
JP |
|
Z
|
Zoetis Inc
XMUN:ZOE
|
US |
|
Country Garden Services Holdings Co Ltd
F:75H
|
CN |
|
C
|
Carnival Corp
LSE:0EV1
|
US |
|
Vinci Compass Investments Ltd
NASDAQ:VINP
|
BR |
Bankruptcy Probability
PTC Therapeutics Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
PTC Therapeutics Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
|
PTC Therapeutics Inc
NASDAQ:PTCT
|
5.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
AbbVie Inc
NYSE:ABBV
|
462.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
228B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences, Inc
NASDAQ:GILD
|
185B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
132.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Moderna Inc
NASDAQ:MRNA
|
76.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
78.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
88.2B AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
53B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Natera Inc
NASDAQ:NTRA
|
59.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Revolution Medicines Inc
NASDAQ:RVMD
|
44B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
PTC Therapeutics Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, PTC Therapeutics Inc has total debt of 2.5B USD. This includes both short-term (0 USD) and long-term (2.5B USD) debt.
You can find a full breakdown on its Balance Sheet.